By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews said today that it has reached a term sheet agreement with GeneDiagnostics for the marketing of its colorectal cancer risk test in parts of China.

Toronto-based GeneNews said that it expects to finalize a formal marketing partnership agreement with the Chinese firm before the end of its current fiscal quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.